Cells on the rise
AACR by the numbers: abstracts by targets, indications, modalities, cell types
This year’s meeting of the American Association for Cancer Research (AACR) will keep the spotlight on immuno-oncology, where preclinical science is continuing to expand the use of different types of innate and adaptive immune cells in a range of different cancers. Other highlights include a rising profile of ovarian cancer and at least 21 new targets covering DNA damage repair or pathways of cancer metabolism.
BioCentury’s second annual analysis of the almost 6,000 AACR abstracts recapitulates several of the themes from last year, showing a steady growth in cancer immunotherapy against a backdrop of decades-old targets that still occupy, at least numerically, a dominant position...
BCIQ Company Profiles
BCIQ Target Profiles
B cell lymphoma 2 (BCL-2) (BCL2)
Cytotoxic T-lymphocyte associated protein 4 (CTLA4) (CD152)
Defective in cullin neddylation 1 domain containing 1 (DCUND1)
Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu)
Karyopherin subunit beta 1 (KPNB1)
Phosphatase and tensin homolog deleted on chromosome ten (PTEN) (MMAC1) (TEP1)